Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
S2N28
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Gam-COVID-Vac
Emergency use authorization Experimental Vaccine Dec/23/2021
Tocilizumab
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Glucocorticoids
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Rosuvastatin
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/20/2021
Emtricitabine
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Tenofovir
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Corticosteroids
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021
Metformin
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/14/2021
mAb Beta-22
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021
mAb Beta-27
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021
Ritonavir
Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Siltuximab
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/29/2021
Fluvoxamine
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/27/2021
ALD-R491
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/12/2021
Hematopoietic stem cells
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/06/2021
LSNME/SW1
Potential treatment - pre-clinical evidence Experimental Vaccine Oct/01/2021
Favipiravir
Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
Cobimetinib
Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Sep/06/2021